
A single subcutaneous dose led to a 4-point or greater itch reduction in 82% of patients with chronic pruritus at week 12 vs 22% with placebo, Attovia reported.
Physicians need to help others. It's within them, a creed to which they'vesworn. In cities reeling from the worst terrorist attacks in U.S. history,frustrated dermatologists wanted to help but couldn't.






